Morpholine → HCID 178520992, compound
Reaction equation
[OH:1][C@@H:2]1[CH2:7][CH2:6][C@H:5]([C:8]([OH:10])=O)[CH2:4][CH2:3]1.ON1C2N=CC=CC=2N=N1.[NH:21]1[CH2:26][CH2:25][O:24][CH2:23][CH2:22]1>ClCCl>[N:21]1([C:8]([C@@H:5]2[CH2:4][CH2:3][C@H:2]([OH:1])[CH2:7][CH2:6]2)=[O:10])[CH2:26][CH2:25][O:24][CH2:23][CH2:22]1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of cis-4-hydroxycyclohexanecarboxylic acid (720 mg, 0.5 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimde hydrochloride (1.33 g, 6 mmol) and 1-hydroxy-7-azabenzotriazole (816 mg, 6 mmol) in dichloromethane (6 ml) was treated with morpholine 1.3 ml, 15 mmol). After stirring at room temperature for 18 hours, the crude reaction was applied to a SCX ion exchange cartridge (Varian bond-elute, 5 g) and washed with methanol and then a mixture of 0.880 ammonia:methanol (1:9). The combined basic fractions were concentrated in vacuo, and the resulting residue was purified by column chromatography eluting with a mixture of 0.880 ammonia:ethanol:dichloromethane (1:9:90) to afford the title compound (D55); MS (ES+) m/e 214 [M+H]+.
Workup
- customthe crude reaction
- washwashed with methanol
- additiona mixture of 0.880 ammonia:methanol (1:9)
- concentrationThe combined basic fractions were concentrated in vacuo
- customthe resulting residue was purified by column chromatography
- washeluting with a mixture of 0.880 ammonia:ethanol:dichloromethane (1:9:90)
Sources & evidence
- ORD record
- ord-cb6c077c693e4d64aff5425d0e54bde4
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07704994B2
Reaction notes
Loading…